Apolipoprotein E, Executive Function, and Falls across Cognitive Status: A Cross-Sectional Study.
Ferdinand Delgado1,2, Fang Yu3, Daniel S Peterson4
1College of Health and Human Services, Department of Kinesiology, University of New Hampshire, Durham, New Hampshire, USA, ferdinanddelgadophd@gmail.com.
Apolipoprotein E4 (ApoE4) does not affect how executive function (EF) relates to falls. However, EF impacts falls differently across cognitive statuses in older adults.
Area of Science:
- Neuroscience
- Gerontology
- Public Health
Background:
- Falls are a major public health concern in older adults.
- Executive function (EF) impairment is a known risk factor for falls.
- The role of Apolipoprotein E4 (ApoE4) in the EF-falls relationship is not well understood.
Purpose of the Study:
- To investigate the moderating effect of ApoE4 on the relationship between EF and falls.
- To examine this relationship across different cognitive statuses: unimpaired cognition, mild cognitive impairment (MCI), and Alzheimer's disease (AD) dementia.
Main Methods:
- Cross-sectional analysis of 486 participants from the Arizona Study of% Aging and Neurodegenerative Disorders.
- EF assessed via a composite latent variable (Trail Making Test, Stroop Interference, Digit Span, Clock Drawing, verbal fluency).
- ApoE genotypes determined; logistic regression used to analyze fall history and future falls.
Main Results:
- ApoE4 did not significantly moderate the EF-falls relationship.
- EF was associated with fall history in individuals with unimpaired cognition and MCI, but not AD dementia.
- Covariates like Parkinson's scale elements, medical conditions, and depression were associated with fall history; medical conditions and fall history with future falls.
Conclusions:
- ApoE4 does not alter the association between EF and falls.
- The influence of EF on falls is dependent on an individual's cognitive status.
More Related Videos
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
Related Concept Videos
Alzheimer's Disease: Overview
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
Cognitive Development During Adulthood
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
